DR CHAN AND PARTNERS LIMITED
No material changes in the last 30 days.
No snapshot from 90 days ago — start tracking from today.
No snapshot from 180 days ago — start tracking from today.
Opportunity 75/100 (strong), bankability 70/100. Strong seller-intent signal (60/100, director aged 68). Share purchase looks the cleaner deal structure. Biggest value-creation lever: Cash flow review and working-capital discipline. Cash down -55% YoY — forensic review of receivables, stock turns, and creditor days. Most likely exit: share sale to pe / searcher (73/100).
Data confidence
Overall: medium (78/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Signals from accounts
Derived from iXBRL accounts · FRS 102Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Total assets | £222.3k | £158.9k |
| Current assets | £313.0k | £240.2k |
| Cash | £48.1k | £108.0k |
| Debtors | £213.9k | £132.2k |
| Net assets | £222.3k | £158.9k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
Corporate timeline (14 events)Click to expand
- 2025-12-31📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2025-06-11📍change-registered-office-address-company-with-date-old-address-new-addressaddress · AD01
- 2024-12-12📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2024-09-05➖CHAN, Andrew resigneddirector
- 2024-09-05📄termination-director-company-with-name-termination-dateofficers · TM01
- 2023-08-11📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2023-08-11📄change-account-reference-date-company-previous-extendedaccounts · AA01
- 2023-02-04📄gazette-filings-brought-up-to-dategazette · DISS40
- 2023-01-31📄gazette-notice-compulsorygazette · GAZ1
- 2021-11-15🏢Company incorporatedAs DR CHAN AND PARTNERS LIMITED
- 2021-11-15➕AGIUS FERNANDEZ, Adriana appointeddirector
- 2021-11-15➕CHAN, Tin Kin, Dr appointeddirector
- 2021-11-15➕CHAN, Andrew appointeddirector
- 2021-11-15📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Founder name in company name: Company name contains director surname "CHAN" — strong identity link between founder and business.
- +Founder age: Director aged approximately 68 — succession pressure is live.
Succession & seller-readiness
Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.
- primaryFounder aged 63+: Senior director is approximately 68. Approaching typical UK retirement age — succession thinking likely.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
Red flags
cleanShareholders & ownership
2 active beneficial owners| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Tin Kin Chan Individual · British · DOB 08/1963 · age 63 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 15/11/2021 |
Ms Adriana Agius Fernandez Individual · British · DOB 05/1958 · age 68 | 25–50% | 25–50% | 25-50% shares · 25-50% voting | 15/11/2021 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · EH postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| SUMMIT HEALTHCARE (WISHAW) LIMITED→ SC182649 · est 1998 | £14.49M £10.43M–£18.54M | — | — | 0 | 28y | 84 | 60y |
| RENAISSANCE CARE (SCOTLAND) LIMITED→ SC190022 · est 1998 | £9.89M £7.12M–£12.66M | — | — | 1356 | 27y | 85 | 72y |
| RENAISSANCE CARE (NO1) LIMITED→ SC402097 · est 2011 | £9.82M £7.07M–£12.57M | — | — | 832 | 15y | 84 | 69y |
| AYRSHIRE HOSPITALS LIMITED→ SC248921 · est 2003 | £4.40M £3.17M–£5.63M | — | — | 0 | 23y | 84 | 64y |
| STONEHOUSE HOSPITALS LIMITED→ SC251033 · est 2003 | £706.3k £508.5k–£904.0k | — | — | 0 | 23y | 92 | 64y |
| RENAISSANCE CARE (UK) LTD→ SC379961 · est 2010 | £438.4k £315.7k–£561.2k | — | — | 4 | 16y | 88 | 69y |
| PRESTIGE NURSING (SCOTLAND) LIMITED→ SC143810 · est 1993 | — | — | — | 28800 | 33y | 84 | 63y |
| ANSWER PROJECT→ SC212773 · est 2000 · no financials extracted | — | — | — | — | 25y | 83 | 79y |
| CRANSTON NURSERIES LIMITED→ SC253519 · est 2003 | — | — | £360.3k | — | 22y | 83 | 76y |
| EDINBURGH SPORTS INJURY CLINIC LIMITED→ SC245755 · est 2003 | — | — | £97.9k | — | 23y | 83 | 61y |
| ELDER HOMES LIMITED→ SC154896 · est 1994 · no financials extracted | — | — | — | — | 31y | 83 | 80y |
| FLORABANK HOME LIMITED→ SC170166 · est 1996 · no financials extracted | — | — | — | — | 29y | 83 | 81y |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 1 resigned)
Click a director name to see their full track record across all companies.